6256 J . Org. Chem., Vol. 62, No. 18, 1997
Baudat and Vogel
54.8, 54.5 (4d), 21.5 (q, OCCH3); 15.3 (q, C(7′)); CI-MS (NH3)
m/ z 355 (3), 354 (7), 322 (20), 292 (20), 278 (15), 250 (25), 160
(26), 146 (81), 123 (47), 109 (88), 97 (80), 81 (100); CI-MS
(electrospray) 354.7 (100); for C14H27O9N (353.16).
might be inhibitors of glycosidases that cleave specifically
â-galactoside-O(1f3) links, what the above enzymes are
not specialized for, apparently. Work will be initiated to
search for such enzymes and for biological systems
capable to interact with our aza-C-disaccharides.
3-Deoxy-3-[(1′S)-2′,6′,7′-tr ideoxy-2′,6′-im in io-â-D-glycer o-
L-ma n n o-h eptitol-1′-yl]-â-D-galactose Tr iflu or oacetate an d
Isom er s ((-)-2r,â,38r,â). A solution of (+)-37 (24 mg, 0.06
mmol) in trifluoroacetic acid/H2O 8:2 (3 mL) was stirred at 37
°C for 15 h. Evaporation led to 23.4 mg (98%) of a mixture of
Con clu sion
The syntheses of branched, long-chain carbohydrates
containing 13 carbon centers, a 1,5,6-trideoxy-1,5-imino-
D-galactitol moiety â-C-linked to various hexoses has been
possible through stereoselective (like mode) aldol con-
densations of a protected 3,4,5-trihydroxy-6-methylpip-
eridine-2-carbaldehyde with the lithium enolates of
(+)-(1R,4S,5S,6S)- and (-)-(1S,4R,5R,6R)-6-chloro-5-
(phenylseleno)-7-oxabicyclo[2.2.1]heptan-2-one. Stereo-
selective transformations of the aldols so-obtained led to
two “branched” aza-C-disaccharides. In the first case,
6-deoxy-D-galactonojirimycin is â-linked at position C(3)
of methyl R- and â-altrofuranoside (1) through a hy-
droxymethylene bridge. In the second case, 6-deoxy-D-
galactonojirimycin is â-linked at position C(3) of D-ga-
lactose, through a hydroxymethylene group. The latter
aza-C-disaccharide resembles somehow the tumor specific
carbohydrate antigen D-Galâ(1f3) GalNAc (Thomsen-
Friedenreich antigen (T)).29 Conjugates with peptides
will be tested as potential “anticancer vaccine”.30
2R,â and 38R,â: a slightly yellow oil; [R]25 ) -4.1, [R]25
)
D
577
-6.2, [R]25 ) -7.0 (c ) 1.2, MeOH); IR (film) ν 3425, 2925,
546
1685, 1435, 1210, 1135, 945, 840, 805, 725 cm-1; 1H NMR (600
MHz, CD3OD) of 2R (signal attributions for 2R in the mixture
relies, when possible, upon 2D spectra (COSY, HMQC, DEPT))
3
3
δ 5.28 (d, 0.2 H, J ) 4.4, HC(1), â-Galf), 5.26 (d, 0.1 H, J )
4.5, HC(1), R-Galf), 5.23 (d, 0.4 H, 3J ) 4.5, HC(1), â-Galp),
3
5.21 (d, 0.3 H, J ) 4.5, HC(1), R-Galp), 4.63-4.55 (m, 1.2 H),
4.52-4.43 (m, 1.5 H), 4.38-4.30 (m, 1.8 H, HC(2), Galf), 4.26-
4.16 (m, 1.5 H, HC(2), Galp, HC(4′)), 4.10-3.85 (m, 6.8 H),
3.77-3.53 (m, 4.8 H), 3.51-3.38 (m, 1.9 H, H-C(6′)), 3.31-
3.22 (m, 1.3 H), 2.80-2.62 (m, 1.5 H, H-C(2′), H-C(3)), 1.48-
1.40 (m, 3 H, H3-C(7′)); 13C-NMR (150.92 MHz, CD3OD) of 2â
and 2R (â-Galp), δ 161.0 (s, CF3COO), 117.3 (q, CF3COO), 96.6
(d, C(1)), 80.8 (d, C(4′)), 75.5, 72.8, 71.8, 70.5, 67.5, 65.3 (6d,
C(2), C(4), C(5), C(1′), C(3′), C(5′)), 64.3 (t, C(6)), 64.2, 56.9,
48.8 (3d, C(6′), C(2′), C(3)), 15.1 (q, C(7′)), (R-Galp), δ 161.2 (s,
CF3COO), 117.3 (q, CF3COO), 96.6 (d, C(1)), 81.8 (d, C(4′)),
78.8, 75.5, 74.4, 71.7, 70.4, 67.4 (6d, C(2), C(4), C(5), C(1′), C(3′),
C(5′)), 64.8 (d, C(6′)), 64.2 (t, C(6)), 56.6, 43.8 (2d, C(2′), C(3)),
15.1 (q, C(7′)); CI-MS (electrospray) 339 (100), 322 (33); CI-
MS (NH3) m/ z 341 (1), 340 (1), 322 (5), 285 (8), 267 (7), 175
(8), 146 (26), 137 (39), 123 (100), 115 (25), 95 (60), 80 (44).
Anal. Calc for C13H25O9N‚CF3COOH (339.34 + 113.99): C,
39.72; H, 5.78. Found: C, 39.84; H, 5.84.
Exp er im en ta l Section
Gen er a l Rem a r k s. See refs 23, 28. None of the proce-
dures were optimized. Flash column chromatography (FC)
was performed on Merck silica gel (230-400 mesh). Thin layer
chromatography (TLC) was carried out on silica gel (Merck
aluminum foils). 1H NMR signal assignments were confirmed
by double irradiation experiments and, when required, by 2-D-
NOESY and COSY spectra. J values are given in hertz. 600
MHz 1H NMR spectra were recorded on a Bruker AMX-600
FT spectrometer.
Meth yl 3-Deoxy-3-[(1′R)-2′,6′,7′-tr id eoxy-2′,6′-im in o-â-
D-glycer o-L-m a n n o-h ep titol-1′-yl]-R- a n d â--D-a ltr ofu r a -
n osid e ((+)-1R,â). Aqueous NH3 (50%, 1 mL) was added to a
stirred solution of (+)-27 (12 mg, 0.02 mmol) in MeOH (2 mL).
After 2 h of stirring, the solvent was evaporated. The residue
was taken up in MeOH (0.2 mL) and 2 N HCl (0.5 mL) and
deposited on a Dowex 50W X8 column (H+ form, 3 g, 200-400
mesh) and washed first with H2O, then with MeOH, and
finally with 5% aqueous NH3 to provide (+)-1R,â (7 mg, 95%)
as a 5:1 mixture of R- and â-anomer which precipitated from
2,3:6,7-Di-O-isop r op ylid en e-D-glycer o-D-gu lo-h ep ton o-
1,4-la ct on e ((-)-4) a n d 3,5:6,7-Di-O-isop r op ylid en e-D-
glycer o-D-gu lo-h ep ton o-1,4-la cton e ((-)-5). D-glycero-D-
gulo-Heptono-1,4-lactone ((-)-3, Aldrich) (8 g, 38.4 mmol),
p-toluenesulfonic acid (0.2 g, 1.05 mmol), and CaSO4 (1 g, 7.64
mmol) were stirred in acetone (80 mL) in an autoclave at 150
°C. After 1.5 h the mixture was neutralized with Na2CO3 and
then filtered. Silica gel (40 g) was added and the suspension
carefully evaporated in vacuo. FC (silica gel (400 g), EtOAc/
petroleum ether 3: 2, then EtOAc) yielded 2.78 g (25%) of (-)-
4, 4.22 g (38%) of (-)-5, and 1.03 g (13%) of starting material
((-)-3). Recyclin g of (-)-5 a n d (-)-3. The same procedure
as above was used starting with D-glycero-D-gulo-heptono-1,4-
lactone ((-)-3) (1 g, 5.0 mmol) and (-)-5 (4.2 g, 14.6 mmol),
yielding 1.0 g (18%) of (-)-4, 2.1 g (37%) of (-)-5 and 0.3 g
(7%) of (-)-3. All spectral and physical data of (-)-4 and (-)-5
were identical to those published.13,14
4-O-Ben zyl-3,7,8-tr id eoxy-3,7-im in o-1,2:5,6-d i-O-isop r o-
p ylid en e-D-th r eo-L-ga la cto-octitol ((-)-10). Heptono-1,4-
lactone (-)-4 was converted into 3,7,8-trideoxy-3,7-imino-1,2:
5,6-di-O-isopropylidene-D-threo-L-galacto-octitol (+)-9 as already
described.15 NaH, 55% in oil (302.4 mg, 6.93 mmol), benzyl
bromide (0.85 mL, 6.93 mmol), and tetrabutylammonium
iodide (60 mg, 0.17 mmol) were added successively to a stirred
solution of (+)-9 (995 mg, 3.46 mmol) in THF (10 mL). After
15 h of stirring, the mixture was poured into aqueous
saturated NaHCO3 solution (100 mL) and the aqueous layer
was extracted with EtOAc (50 mL, 4 times). The combined
organic extracts were dried (MgSO4), the solvent was evapo-
rated, and the residue was purified by FC (silica gel (20 g),
EtOAc/petroleum ether, 1:4): 1.03 g (79%) of (-)-10, colorless
oil; [R]25D ) -1.9 (c ) 1.5, CHCl3); 1H NMR (400 MHz, CDCl3)
MeOH/Et2O: mp 208-210 °C dec; [R]25 ) +1.3, [R]25
)
D
577
+1.8, [R]25 ) +2.2, [R]25 ) +3.4, [R]25 ) +4.0 (c ) 0.7,
546
435
405
MeOH); IR (KBr) ν 3135, 2010, 1765, 1410 cm-1; 1H NMR (600
MHz, CD3OD/D2O, pH 5.7) δ 4.80 (br s, HC(1)), 4.36 (d, 3J (2,3)
) 1.3, HC(2)), 4.28 (dd, 3J (1′,3) ) 10.1, 3J (1′,2′) ) 1.5, HC(1′)),
4.04 (d, 3J (2′,3′) ) 10.2, 3J (3′,4′) ) 9.8, HC(3′)), 4.00 (ddd,
3
3
3J (4′,5′) ) 2.8, J (5′,6′) ) 0.8, HC(5′)), 3.92 (dd, J (4,5) ) 8.4,
3J (3,4) ) 5.3, HC(4)), 3.88 (dd, 2J ) 11.8, 3J ) 2.6) & 3.73 (dd,
11.8, 5.0, H2C(6)), 3.77 (ddd, 8.4, 5.0, 2.6, HC(5)), 3.69 (dd, 9.5,
2.8, HC(4′)), 3.54 (qd, 6.7, 0.8, HC(6′)), 3.20 (dd, 10.2, 1.5,
HC(2′)), 2.40 (ddd, 10.1, 5.3, 1.3, HC(3)), 1.43 (d, 6.7, Me-C(6′));
13C-NMR (100.61 MHz, CDCl3, 50 °C) δ 110.9 (d, C(1)), 79.3,
79.0, 76.3, 75.3, 71.2, 67.0, 66.7 (7d), 64.4 (t, C(6)), 62.2, 56.1,
2
3
(29) Springer, G. F. Science 1984, 224, 1198. MacLean, G. D.,
Longenecker, B. L. Semin. Cancer Biol. 1991, 2, 443. Samuel, J .;
Nouaim, A. A.; MacLean, G. D.; Suresh, M. R.; Longenecker, B. M.
Cancer Res. 1990, 250, 4801. Zhuang, D.; Yousef, S.; Dennis, J . W.
Cancer Biochem. Biophys. 1991, 12, 185. Rabinovich, N. R.; McInnes,
P.; Klein, D. L.; Hall, P. F. Science 1994, 265, 1401.
(30) See, e.g.: MacLean, G. D.; Reddish, M.; Koganty, R. R.; Wong,
T.; Gaudhi, S.; Smolenski, M.; Samuel, J .; Nabholtz, J . M.; Longe-
necker, B. M. Cancer Immunol. Immunother. 1993, 36, 215. See also:
Hanessian, S.; Qiu, D.; Prabhanjan, H.; Reddy, G. V.; Lou, B. Can. J .
Chem.1996, 74, 1738.
δ 7.36-7.26 (d, m), 4.93, 4.57 (2d, J ) 11.4), 4.24 (ddd, J )
3
3
7.9, 6.2, 5.2), 4.12 (dd, J ) 6.9, 5.4), 4.05 (dd, J ) 5.4, 2.6),
2
3
2
3
3.97 (dd, J ) 8.1, J ) 6.2), 3.89 (dd, J ) 8.1, J ) 7.9), 3.41
(dd, 3J ) 10.0, 6.9), 3.03 (dd, 3J ) 6.7, 2.6), 2.44 (dd, 3J ) 10.0,
3
5.2), 1.55, 1.42, 1.40, 1.34 (4s), 1.28 (d, J ) 6.7).
4-O-Ben zyl-N-(ben zyloxyca r bon yl)-3,7,8-tr id eoxy-3,7-
im in o-1,2:5,6-d i-O-isop r op ylid en e-D-th r eo-L-ga la cto-octi-
tol ((+)-11). Meth od A (fr om (-)-10). NaHCO3 (400 mg,
4.80 mmol) and benzyl chloroformate (0.48 mL, 3.28 mmol)